According to a pro-life research organization, the lackluster
success rates have made funding for embryonic stem-cell
research more difficult to come by.
A new report from the education and research arm of the Susan B.
Anthony List shows that the scientific community now recognizes
that "morally unproblematic alternatives to embryonic stem cells
[are] the best hope for progress toward effective treatments and
The scientific community now understands that the best chance
for success with treating medical conditions is through adult stem
Chuck Donovan is president
of the Charlotte Lozier Institute. He says researchers
are pursuing more ethical approaches.
"We've analyzed the last five years of funding by the San
Francisco-based California Institute for Regenerative Medicine
(CIRM), which was created to promote embryonic stem-cell research
that hopefully would lead to therapies and cures for various
diseases," Donovan explains. "It was promised to do that. Our
analysis shows that they have been unable to find projects that
work that way, and they are now turning more and more to adult
stem-cell resources, which do not raise those ethical issues of
destroying human embryos."
While no successful uses of human embryo research have been
found, research with adult stem cells has shown promise in treating
over 70 diseases and medical conditions.
Donovan concludes the survey shows that even the most
supportive entity in the country, CIRM, cannot find beneficial
projects for human embryo research and is turning to adult